Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
about
Optimum duration of regimens for Helicobacter pylori eradicationAntibiotic treatment for Helicobacter pylori: Is the end coming?Peptic ulcer disease todayExternal validation of a measurement tool to assess systematic reviews (AMSTAR).Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian populationEffect of CYP2C19 Gene Polymorphisms on Proton Pump Inhibitor, Amoxicillin, and Levofloxacin Triple Therapy for Eradication of Helicobacter PyloriManagement of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusEvidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.American College of Gastroenterology guideline on the management of Helicobacter pylori infection.Review article: diagnosis and treatment of Helicobacter: a 2002 updated review.Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication.Trends in peptic ulcer pharmacotherapy.Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.Acid suppression therapy: where do we go from here?Effective regimens for the treatment of Helicobacter pylori infection.Evolution of Helicobacter pylori therapy from a meta-analytical perspective.Current pharmacotherapy options for gastritis.Current options for the treatment of Helicobacter pylori.Review: efficacy and safety of hybrid therapy for Helicobacter pylori infection: a systematic review and meta-analysis.Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era.Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection.Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies.High-dose versus standard-dose PPI in triple therapy for Helicobacter pylori eradication.The diagnosis and management of H. pylori infection in Singapore.Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionFirst-line eradication of Helicobacter pylori: are the standard triple therapies obsolete? A different perspective.Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection.Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment?Measuring and estimating treatment effect on dichotomous outcome of a population.Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication.Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial.A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication.Helicobacter pylori: factors affecting eradication and recurrence.The Suppressive Effects of Geniposide and Genipin on Helicobacter pylori Infections In Vitro and In Vivo.Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers.Letter: levofloxacin resistance - a challenge for treatment of Helicobacter pylori infection. Authors' reply.Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicen
P2860
Q24201841-9A8A0A84-9D8E-476A-8B7A-725A4B63B96FQ26777623-8CBC1BB3-DD09-4203-BE61-92D0B75D2677Q28194844-2E6B5496-2340-4492-9CB8-4A4C210F341AQ33312366-A6610225-C18E-4F29-A6B6-647A7B2DF6E9Q33787766-47E21047-5599-4536-A3FE-52090C0042D6Q33787853-73BE53E9-044B-42F9-8818-2C87BEE5CAC1Q34067951-56D538D7-5440-4C8A-AF5D-47A0611D32E4Q34404967-0EFD25F8-52D9-40B0-A2CA-0805AAF99AFAQ34645482-DAABE59B-28EB-4695-97D0-2D95B8D3197FQ35145059-4FF6BC2D-507B-4319-8AA7-A9537F6672A0Q35216889-68164BE2-74DB-42FC-907F-E2C0F8B45A15Q35641362-35171164-35FE-4F5C-B980-04C28E43ADAEQ36214570-1D23A76E-1786-46AB-8FB2-C4BA999E60E8Q36322095-B00C7F65-CAE7-4BB1-8579-CAE6A6E13BA8Q36478082-9BBFB773-3C3B-4181-85A4-EAE983585AE1Q36568724-E590F16D-FB22-41B1-A748-49BAD2419735Q36996627-A3720CAB-29E1-4278-BB38-E5C9C739F5B2Q38061147-789C59BA-C306-420B-BCFF-30A65E1CF306Q38075061-2C5071A3-6522-4547-9C6B-39B8F0655222Q38266303-851318A1-A088-4656-B64B-08CB603FEFB2Q38578674-DB21172C-556E-461B-8763-E9A12303B70AQ39146021-7784419F-3036-4EA5-9BC2-01A25DB41FF6Q39278632-C5C5D8CB-0926-462A-BE93-AD0FA8958119Q39618441-3C547783-2FE4-459F-A523-13A164B86539Q40201360-4B3F5A75-3882-49B2-A46A-86D5CA111CB6Q41074387-AE49C3A4-CDA5-41EC-BA71-555FF93FFF30Q42371575-C19AFBFE-BB40-4C6F-8241-AFD1897BBE4BQ42531897-4E485A34-27C5-4D66-AF3A-10FF18691DC3Q43708032-5245B6A3-3887-4A87-B89E-5E2DA5A7DD1CQ44142867-4C13AD05-35AC-4C78-864F-FCB7AFB41F59Q44522961-F118FEBE-1217-49B3-93C3-C80110026965Q44611972-88DECA6F-B88B-4754-A815-AE48F4079B3DQ44665326-990BFDFE-3D38-495A-8488-3C878544F936Q44993690-8D076D22-5DAE-49A9-A236-CF196C5E0355Q46798229-F5C78CF0-33BD-4A7A-9C12-9EDC1E5B280EQ46798232-FCBEEDFB-E6A4-4C2B-9A0C-2E553E91815BQ47709324-381D2A40-B434-402A-A5E3-714F27B09308Q51368572-0B4A35D1-7A4C-4DE8-B7A0-43A8077BC5DFQ53754360-1D38278B-6BDA-4444-83CE-639929F4EAE8Q58700546-2298D2CA-48CE-4A8F-A230-4DC9767F2079
P2860
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Single vs. double dose of a pr ...... eradication: a meta-analysis.
@ast
Single vs. double dose of a pr ...... eradication: a meta-analysis.
@en
Single vs. double dose of a pr ...... eradication: a meta-analysis.
@nl
type
label
Single vs. double dose of a pr ...... eradication: a meta-analysis.
@ast
Single vs. double dose of a pr ...... eradication: a meta-analysis.
@en
Single vs. double dose of a pr ...... eradication: a meta-analysis.
@nl
prefLabel
Single vs. double dose of a pr ...... eradication: a meta-analysis.
@ast
Single vs. double dose of a pr ...... eradication: a meta-analysis.
@en
Single vs. double dose of a pr ...... eradication: a meta-analysis.
@nl
P2860
P50
P1476
Single vs. double dose of a pr ...... i eradication: a meta-analysis
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2002.01270.X
P407
P577
2002-06-01T00:00:00Z